|
1
|
Beckman JA, Creager MA and Libby P:
Diabetes and atherosclerosis: Epidemiology, pathophysiology, and
management. JAMA. 287:2570–2581. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Barsness GW, Peterson ED, Ohman EM, Nelson
CL, DeLong ER, Reves JG, Smith PK, Anderson RD, Jones RH, Mark DB
and Califf RM: Relationship between diabetes mellitus and long-term
survival after coronary bypass and angioplasty. Circulation.
96:2551–2556. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Natarajan MK, Strauss BH, Rokoss M, Buller
CE, Mancini GB, Xie C, Sheth TN, Goodhart D, Cohen EA, Seidelin P,
et al: Randomized trial of insulin versus usual care in reducing
reste-nosis after coronary intervention in patients with diabetes.
The STent restenosis and metabolism (STREAM) study. Cardiovasc
Revasc Med. 13:95–100. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
El Akoum S, Cloutier I and Tanguay JF:
Vascular smooth muscle cell alterations triggered by mice
adipocytes: Role of high-fat diet. J Atheroscler Thromb.
19:1128–1141. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hattori Y, Hattori S, Sato N and Kasai K:
High-glucose-induced nuclear factor kappaB activation in vascular
smooth muscle cells. Cardiovasc Res. 46:188–197. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu WY, Yan H, Wang XB, Gui YZ, Gao F, Tang
XL, Qin YL, Su M, Chen T and Wang YP: Sodium tanshinone IIA silate
inhibits high glucose-induced vascular smooth muscle cell
proliferation and migration through activation of AMP-activated
protein kinase. PLoS One. 9:e949572014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Virmani R, Kolodgie FD, Burke AP, Farb A
and Schwartz SM: Lessons from sudden coronary death: A
comprehensive morphological classification scheme for
atherosclerotic lesions. Arterioscler Thromb Vasc Biol.
20:1262–1275. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bajaj A and Sethi A, Rathor P, Suppogu N
and Sethi A: Acute complications of myocardial infarction in the
current Era: Diagnosis and management. J Investig Med. 63:844–855.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Libby P, Ridker PM and Hansson GK:
Progress and challenges in translating the biology of
atherosclerosis. Nature. 473:317–325. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bennett MR, Sinha S and Owens GK: Vascular
smooth muscle cells in atherosclerosis. Circ Res. 118:692–702.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim J, Jang SW, Park E, Oh M, Park S and
Ko J: The role of heat shock protein 90 in migration and
proliferation of vascular smooth muscle cells in the development of
atherosclerosis. J Mol Cell Cardiol. 72:157–167. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pan HW, Li SC and Tsai KW: MicroRNA
dysregulation in gastric cancer. Curr Pharm Des. 19:1273–1284.
2013.
|
|
13
|
Lim LP, Lau NC, Garrett-Engele P, Grimson
A, Schelter JM, Castle J, Bartel DP, Linsley PS and Johnson JM:
Microarray analysis shows that some microRNAs downregulate large
numbers of target mRNAs. Nature. 433:769–773. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhou Y, Li S, Li J, Wang D and Li Q:
Effect of microRNA-135a on Cell Proliferation, migration, invasion,
apoptosis and tumor angio-genesis through the IGF-1/PI3K/Akt
signaling pathway in non-small cell lung cancer. Cell Physiol
Biochem. 42:1431–1446. 2017. View Article : Google Scholar
|
|
16
|
Wu P, Agnelli L, Walker BA, Todoerti K,
Lionetti M, Johnson DC, Kaiser M, Mirabella F, Wardell C, Gregory
WM, et al: Improved risk stratification in myeloma using a
microRNA-based classifier. Br J Haematol. 162:348–359. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tian Z, Zhao JJ, Tai YT, Amin SB, Hu Y,
Berger AJ, Richardson P, Chauhan D and Anderson KC: Investigational
agent MLN9708/2238 targets tumor-suppressor miR33b in MM cells.
Blood. 120:3958–3967. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li T, Yang GM, Zhu Y, Wu Y, Chen XY, Lan
D, Tian KL and Liu LM: Diabetes and hyperlipidemia induce
dysfunction of VSMCs: Contribution of the metabolic
inflammation/miRNA pathway. Am J Physiol Endocrinol Metab.
308:E257–E269. 2015. View Article : Google Scholar
|
|
19
|
Mackenzie NC, Staines KA, Zhu D, Genever P
and Macrae VE: miRNA-221 and miRNA-222 synergistically function to
promote vascular calcification. Cell Biochem Funct. 32:209–216.
2014. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen Q, Yang F, Guo M, Wen G, Zhang C,
Luong le A, Zhu J, Xiao Q and Zhang L: miRNA-34a reduces neointima
formation through inhibiting smooth muscle cell proliferation and
migration. J Mol Cell Cardiol. 89:75–86. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hayashita Y, Osada H, Tatematsu Y, Yamada
H, Yanagisawa K, Tomida S, Yatabe Y, Kawahara K, Sekido Y and
Takahashi T: A polycistronic microRNA cluster, miR-17-92 is
overexpressed in human lung cancers and enhances cell
proliferation. Cancer Res. 65:9628–9632. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhao D, Chen Y, Chen S, Zheng C, Hu J and
Luo S: MiR-19a regulates the cell growth and apoptosis of
osteosarcoma stem cells by targeting PTEN. Tumour Biol.
39:10104283177053412017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhong B, Guo S, Zhang W and Zhang C, Wang
Y and Zhang C: Bioinformatics prediction of miR-30a targets and its
inhibition of cell proliferation of osteosarcoma by up-regulating
the expression of PTEN. BMC Med Genomics. 10:642017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Roberts PJ, Mitin N, Keller PJ, Chenette
EJ, Madigan JP, Currin RO, Cox AD, Wilson O, Kirschmeier P and Der
CJ: Rho Family GTPase modification and dependence on CAAX
motif-signaled posttranslational modification. J Biol Chem.
283:25150–25163. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Etienne-Manneville S and Hall A: Rho
GTPases in cell biology. Nature. 420:629–635. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Meyer N, Peyret-Lacombe A, Canguilhem B,
Médale-Giamarchi C, Mamouni K, Cristini A, Monferran S, Lamant L,
Filleron T, Pradines A, et al: RhoB promotes cancer initiation by
protecting keratinocytes from UVB-induced apoptosis but limits
tumor aggressiveness. J Invest Dermatol. 134:203–212. 2014.
View Article : Google Scholar
|
|
27
|
Calvayrac O, Pradines A, Raymond-Letron I,
Rouquette I, Bousquet E, Lauwers-Cances V, Filleron T, Cadranel J,
Beau-Faller M, Casanova A, et al: RhoB determines tumor
aggressiveness in a murine EGFRL858R-induced adenocarcinoma model
and is a potential prognostic biomarker for lepidic lung cancer.
Clin Cancer Res. 20:6541–6550. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Huang M and Prendergast GC: RhoB in cancer
suppression. Histol Histopathol. 21:213–218. 2006.
|
|
29
|
Niu S, Ma X, Zhang Y, Liu YN, Chen X, Gong
H, Yao Y, Liu K and Zhang X: MicroRNA-19a and microRNA-19b promote
the malignancy of clear cell renal cell carcinoma through targeting
the tumor suppressor RhoB. PLoS One. 13:e01927902018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen Q, Guo W, Zhang Y, Wu Y and Xiang J:
MiR-19a promotes cell proliferation and invasion by targeting RhoB
in human glioma cells. Neurosci Lett. 628:161–166. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chan KC, Wu CH, Huang CN, Lan KP, Chang WC
and Wang CJ: Simvastatin inhibits glucose-stimulated vascular
smooth muscle cell migration involving increased expression of RhoB
and a block of Ras/Akt signal. Cardiovasc Ther. 30:75–84. 2012.
View Article : Google Scholar
|
|
32
|
Chan KC, Lin MC, Huang CN, Chang WC and
Wang CJ: Mulberry 1-deoxynojirimycin pleiotropically inhibits
glucose-stimulated vascular smooth muscle cell migration by
activation of AMPK/RhoB and down-regulation of FAK. J Agric Food
Chem. 61:9867–9875. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang N, Fu L, Bu Y, Yao Y and Wang Y:
Downregulated expression of miR-223 promotes Toll-like
receptor-activated inflammatory responses in macrophages by
targeting RhoB. Mol Immunol. 91:42–48. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
35
|
Malumbres M and Barbacid M: Mammalian
cyclin-dependent kinases. Trends Biochem Sci. 30:630–641. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Boutros R, Lobjois V and Ducommun B: CDC25
phosphatases in cancer cells: Key players? Good targets? Nat Rev
Cancer. 7:495–507. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ray D, Terao Y, Nimbalkar D, Hirai H,
Osmundson EC, Zou X, Franks R, Christov K and Kiyokawa H:
Hemizygous disruption of Cdc25A inhibits cellular transformation
and mammary tumorigenesis in mice. Cancer Res. 67:6605–6611. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Blomberg I and Hoffmann I: Ectopic
expression of Cdc25A accelerates the G(1)/S transition and leads to
premature activation of cyclin E- and cyclin A-dependent kinases.
Mol Cell Biol. 19:6183–6194. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Timofeev O, Cizmecioglu O, Settele F,
Kempf T and Hoffmann I: Cdc25 phosphatases are required for timely
assembly of CDK1-cyclin B at the G2/M transition. J Biol Chem.
285:16978–16990. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cai FG, Xiao JS and Ye QF: Effects of
ischemic preconditioning on cyclinD1 expression during early
ischemic reperfusion in rats. World J Gastroenterol. 12:2936–2940.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Gopalakrishnan N, Saravanakumar M,
Madankumar P, Thiyagu M and Devaraj H: Colocalization of β-catenin
with Notch intracellular domain in colon cancer: A possible role of
Notch1 signaling in activation of CyclinD1-mediated cell
proliferation. Mol Cell Biochem. 396:281–293. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Visse R and Nagase H: Matrix
metalloproteinases and tissue inhibitors of metalloproteinases:
Structure, function, and biochemistry. Circ Res. 92:827–839. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chambers AF and Matrisian LM: Changing
views of the role of matrix metalloproteinases in metastasis. J
Natl Cancer Inst. 89:1260–1270. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Polette M, Nawrocki-Raby B, Gilles C,
Clavel C and Birembaut P: Tumour invasion and matrix
metalloproteinases. Crit Rev Oncol Hematol. 49:179–186. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Li WD, Hu N, Lei FR, Wei S, Rong JJ,
Zhuang H and Li XQ: Autophagy inhibits endothelial progenitor cells
migration via the regulation of MMP2, MMP9 and uPA under normoxia
condition. Biochem Biophys Res Commun. 466:376–380. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Fatar M, Stroick M, Griebe M and Hennerici
M: Matrix metal-loproteinases in cerebrovascular diseases.
Cerebrovasc Dis. 20:141–151. 2005. View Article : Google Scholar
|
|
47
|
Yuan SM: α-Smooth muscle actin and ACTA2
gene expressions in vasculopathies. Braz J Cardiovasc Surg.
30:644–649. 2015.
|
|
48
|
Zhang JC, Kim S, Helmke BP, Yu WW, Du KL,
Lu MM, Strobeck M, Yu Q and Parmacek MS: Analysis of
SM22alpha-deficient mice reveals unanticipated insights into smooth
muscle cell differentiation and function. Mol Cell Biol.
21:1336–1344. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Wang J, Zhou H, Han Y, Liu X, Wang M, Wang
X, Yin G, Li X and Xiang M: SOCS3 methylation in synergy with Reg3A
over-expression promotes cell growth in pancreatic cancer. J Mol
Med (Berl). 92:1257–1269. 2014. View Article : Google Scholar
|
|
50
|
Chen Y, Wang W, Chen Y, Tang Q, Zhu W, Li
D and Liao L: MicroRNA-19a-3p promotes rheumatoid arthritis
fibroblast-like synoviocytes via targeting SOCS3. J Cell Biochem.
2019.Epub ahead of print.
|
|
51
|
Li Y, Luo T, Wang L, Wu J and Guo S:
MicroRNA-19a-3p enhances the proliferation and insulin secretion,
while it inhibits the apoptosis of pancreatic β cells via the
inhibition of SOCS3. Int J Mol Med. 38:1515–1524. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Tian Q, Streuli M, Saito H, Schlossman SF
and Anderson P: A polyadenylate binding protein localized to the
granules of cytolytic lymphocytes induces DNA fragmentation in
target cells. Cell. 67:629–639. 1991. View Article : Google Scholar : PubMed/NCBI
|
